Researchers at the UConn Center on Aging have uncovered causal links between depression and Alzheimer’s disease and related ...

Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...

Dr. Ausim Azizi is among those seeing the overall early results, as Yale New Haven Hospital is in the forefront of research ...

Long-term data presented at the Alzheimer’s Association International Conference show Leqembi can help patients stay in the ...

The Alzheimer’s Association has issued its first clinical practice guideline on the use of blood tests to help diagnose ...

Kisunla’s active substance is donanemab, a monoclonal antibody that targets and clears amyloid-beta plaques in the brain, a ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

Adopting intensive lifestyle changes can slow or stop progression of early-stage Alzheimer’s disease, according to a new study.

More than seven million Americans are living with Alzheimer’s, a disease that takes a heavy toll on families emotionally and financially.

Let’s keep it simple: If you want to delay Alzheimer’s onset, focus on walking and adding nutritious foods, such as walnuts, ...

New tests and new treatments are presenting more options for certain patients with Alzheimer's disease. “Today a confluence ...